Purchase Order 75N94023P00798
Award Date 9/7/23
Potential Completion Date 9/30/23
Potential Value $10K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20853, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price purchase order to Seqmatic, LLC for RNA sequencing services under the FY26 UDO Initiative. The contract, valued at $14,355, covers sequencing analysis of 76 samples with an ultimate completion date of October 18, 2025. This award was made without a set-aside designation. Seqmatic, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California, specializes in...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,304.00 firm fixed-price purchase order contract to Lifesct LLC, a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business located in Rockville, Maryland. The contract is for the provision of 293 TRANSFECTION REAGENT, with a period of performance through January 25, 2019. This award does not appear to have...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), awarded a $234,964.27 firm-fixed-price purchase order to Government Scientific Source Inc., a small business, to provide a bundled set of 10x Genomics reagents and an instrument upgrade for single-cell and spatial transcriptomics research projects. The contract includes Single-cell RNA-seq reagents, Single-cell RNA + TCR-seq kits, spatial transcriptomics reagents, and an...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Yotta Biomed LLC for $47,999.90 on February 11, 2015, for testing and analytics of bioinformatics for next-generation sequencing data in the NIDDK Genomics Core. The awardee is a minority-owned, Asian-Pacific American owned small business. Work is performed in Potomac, Maryland. The period of performance runs from February 11, 2015 through February 10, 2016. Pricing is firm fixed price with no...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Seqmatic, LLC for $49,700 on January 28, 2021. Seqmatic is a minority-owned, Asian-Pacific American-owned small business. The order procures single-cell RNA sequencing for induced pluripotent stem cells (iPSCs). Performance occurs in Fremont, California, with an ultimate completion date of April 28, 2021. The purchase order carries firm fixed price terms and originated from a pre-solicitation...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>
- This federal contract award, with ID HHSN276201000809P, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The $20,020 purchase order was awarded to Landy Resources, LLC, a minority-owned and self-certified small disadvantaged business, to provide transgenic mice services. The contract does not have a set-aside designation. Landy Resources, LLC also holds a $100 million indefinite...
- <p>This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian agency, to Quick Biology Inc., a self-certified small disadvantaged business. The contract, valued at $102,060.00, is for SNRNASEQ analysis of senolytics in the aging kidney and lung. The contract has a total small business set-aside designation and a performance period ending on May 8, 2025. No additional subcontractors were indicated in the provided information.</p>
- The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $5,283.19 firm fixed price purchase order to Illumina, Inc. for genetic analysis products. The contract has a period of performance from January 6, 2017 through June 30, 2017 for products to be delivered to the agency location in Bethesda, Maryland. No additional details were provided regarding subcontractors or the specific genetic analysis...